Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor | Zendy

Alan Bolnick | Zendy; Jay M. Bolnick | Zendy; HamidReza KohanGhadr | Zendy; Brian A. Kilburn | Zendy; Omar J. Pasalodos | Zendy; Pankaj Singhal | Zendy; Jing Dai | Zendy; Michael P. Diamond | Zendy; D. Randall Armant | Zendy; Sascha Drewlo | Zendy

Open Access

Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor

Author(s) -

Alan Bolnick,

Jay M. Bolnick,

HamidReza KohanGhadr,

Brian A. Kilburn,

Omar J. Pasalodos,

Pankaj Singhal,

Jing Dai,

Michael P. Diamond,

D. Randall Armant,

Sascha Drewlo

Publication year - 2017

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dex069

Subject(s) - trophoblast , biology , epidermal growth factor , growth factor , microbiology and biotechnology , preeclampsia , endocrinology , medicine , placenta , andrology , cell culture , fetus , receptor , pregnancy , biochemistry , genetics

Does low molecular weight heparin (LMWH) require heparin-binding epidermal growth factor (EGF)-like growth factor (HBEGF) signaling to induce extravillous trophoblast differentiation and decrease apoptosis during oxidative stress?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research